{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:53:24Z","timestamp":1769086404132,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1694,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Parvovirus B19 (B19V) is often assumed to be a cause of dilated cardiomyopathy (DCM), based on the quantification of B19V DNA in endomyocardial biopsies (EMB). Whether the presence of B19V DNA correlates with active infection is still debated. Application of the enzyme endonuclease to blood samples results in degradation of B19V DNA remnants but leaves viral particles intact, which enables differentiation between active and past infection. In this study, the susceptibility to degradation by endonuclease of B19V DNA in blood was compared between DCM patients and a control group of recent B19V infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Twenty blood samples from 20 adult patients with DCM, who previously tested positive for B19V DNA in EMB and\/or blood, were tested with B19V PCR before and after application of endonuclease to the samples. Six blood samples tested positive for B19V DNA with a mean viral load of 2.3 \u00d7 104 IU\/mL. In five samples, B19V DNA became undetectable after endonuclease (100% load reduction); in one sample DNA load showed a 23% log load reduction (viral load before endonuclease: 9.1 \u00d7 104 IU\/mL; after: 6.5 \u00d7 103 IU\/mL). Presence of cardiac inflammation did not differ between patients with B19V DNAemia (1\/4) and patients without B19V DNAemia (6\/14) (P value = 1.0). In all 18 control samples of proven recent B19V infections, DNA remained detectable after application of endonuclease, showing only a mean log load reduction of 2.3% (mean viral load before endonuclease: 8.1 \u00d7 1011 IU\/mL; after: 8.0 \u00d7 1011 IU\/mL). Load reduction differed significantly between the DCM group and the control group; indicating the presence of intact viral particles in the control group with proven active infection and the presence of DNA remnants in the DCM group (P value = 0.000).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>During recent B19V infection, viral DNA levels in blood were unaffected by endonuclease. In contrast, B19V DNA in blood in patients with DCM became undetectable or strongly reduced after application of endonuclease. Circulating viral DNA in this subset of patients with presumed parvovirus-associated DCM does not consist of intact viral particles. Viral replicative activity cannot be assumed from demonstrating B19V DNA in cardiac tissue or in blood in DCM patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13341","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T04:12:14Z","timestamp":1619842334000},"page":"2723-2730","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Parvovirus B19 DNA Detectable in Hearts of Patients with Dilated Cardiomyopathy, but Absent or Inactive in Blood"],"prefix":"10.1093","volume":"8","author":[{"given":"Anne","family":"Russcher","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center , Albinusdreef 2, 2333 ZA, E4P 9600, Leiden, 2300 RC ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Job","family":"Verdonschot","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijke W.A.","family":"Molenaar-de Backer","sequence":"additional","affiliation":[{"name":"Department of Blood-borne Infections, Donor Medicine Research, Sanquin Blood Supply Foundation , Amsterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane R.B.","family":"Heymans","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloys C.M.","family":"Kroes","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center , Albinusdreef 2, 2333 ZA, E4P 9600, Leiden, 2300 RC ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans L.","family":"Zaaijer","sequence":"additional","affiliation":[{"name":"Department of Blood-borne Infections, Donor Medicine Research, Sanquin Blood Supply Foundation , Amsterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"2026012114210135300_ehf213341-bib-0001","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012514","article-title":"Role of targeted therapy in dilated cardiomyopathy: the challenging road toward a personalized approach","volume":"8","author":"Verdonschot","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026012114210135300_ehf213341-bib-0002","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(95)90850-1","article-title":"Persistent parvovirus B19 infection","volume":"345","author":"Kerr","year":"1995","journal-title":"Lancet (London, England)"},{"key":"2026012114210135300_ehf213341-bib-0003","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/444503","article-title":"Slow clearance of human parvovirus B19 viremia following acute infection","volume":"41","author":"Lindblom","year":"2005","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America."},{"key":"2026012114210135300_ehf213341-bib-0004","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0369-8114(02)00307-3","article-title":"Persistence of human parvovirus B19 in human tissues","volume":"50","author":"Soderlund-Venermo","year":"2002","journal-title":"Pathol Biol"},{"key":"2026012114210135300_ehf213341-bib-0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2014.06.017","article-title":"Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process","volume":"190","author":"Adamson-Small","year":"2014","journal-title":"Virus Res"},{"key":"2026012114210135300_ehf213341-bib-0006","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1086\/648074","article-title":"Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis","volume":"49","author":"Kuethe","year":"2009","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America."},{"key":"2026012114210135300_ehf213341-bib-0007","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/jmv.21821","article-title":"Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury","volume":"82","author":"Lotze","year":"2010","journal-title":"J Med Virol"},{"key":"2026012114210135300_ehf213341-bib-0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.110.958249","article-title":"Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure","volume":"4","author":"Stewart","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026012114210135300_ehf213341-bib-0009","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.carpath.2012.02.002","article-title":"Parvovirus B19 is a bystander in adult myocarditis","volume":"21","author":"Koepsell","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"2026012114210135300_ehf213341-bib-0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/JCM.01672-08","article-title":"High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy","volume":"47","author":"Schenk","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2026012114210135300_ehf213341-bib-0011","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12024-014-9570-7","article-title":"The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts","volume":"10","author":"Nielsen","year":"2014","journal-title":"Forensic Sci Med Pathol"},{"key":"2026012114210135300_ehf213341-bib-0012","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0046-8177(03)00078-9","article-title":"Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens","volume":"34","author":"Pankuweit","year":"2003","journal-title":"Hum Pathol"},{"key":"2026012114210135300_ehf213341-bib-0013","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1161\/CIRCULATIONAHA.105.548156","article-title":"Viral persistence in the myocardium is associated with progressive cardiac dysfunction","volume":"112","author":"Kuhl","year":"2005","journal-title":"Circulation"},{"key":"2026012114210135300_ehf213341-bib-0014","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMc0911362","article-title":"Human parvovirus B19-associated myocarditis","volume":"362","author":"Bock","year":"2010","journal-title":"N Engl J Med"},{"key":"2026012114210135300_ehf213341-bib-0015","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/CVI.00281-12","article-title":"Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseases","volume":"19","author":"Dennert","year":"2012","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"2026012114210135300_ehf213341-bib-0016","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/ejhf.665","article-title":"Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature","volume":"18","author":"Verdonschot","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114210135300_ehf213341-bib-0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcv.2016.09.004","article-title":"Detection of parvovirus B19 DNA in blood: viruses or DNA remnants?","volume":"84","author":"Molenaar-de Backer","year":"2016","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology."},{"key":"2026012114210135300_ehf213341-bib-0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcv.2017.07.017","article-title":"On the utility of the benzonase treatment for correct laboratory diagnosis of parvovirus B19 infection","volume":"95","author":"Reber","year":"2017","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"key":"2026012114210135300_ehf213341-bib-0019","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/trf.13334","article-title":"Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA","volume":"56","author":"Molenaar-de Backer","year":"2016","journal-title":"Transfusion"},{"key":"2026012114210135300_ehf213341-bib-0020","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/eurheartj\/ehx808","article-title":"Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias","volume":"39","author":"Verdonschot","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012114210135300_ehf213341-bib-0021","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/vox.12295","article-title":"Look-back study on recipients of parvovirus B19 (B19V) DNA-positive blood components","volume":"109","author":"Juhl","year":"2015","journal-title":"Vox Sang"},{"key":"2026012114210135300_ehf213341-bib-0022","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: a review of 98 cases","volume":"43","author":"Eid","year":"2006","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"2026012114210135300_ehf213341-bib-0023","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jcv.2012.04.023","article-title":"Human parvovirus B19 genotype 3 associated with chronic anemia after stem cell transplantation, missed by routine PCR testing","volume":"54","author":"Knoester","year":"2012","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology."},{"key":"2026012114210135300_ehf213341-bib-0024","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1093\/ndt\/gfm531","article-title":"Relapsing severe anaemia due to primary parvovirus B19 infection after renal transplantation: a case report and review of the literature","volume":"22","author":"Beckhoff","year":"2007","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"2026012114210135300_ehf213341-bib-0025","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/ndt\/17.10.1840","article-title":"Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy","volume":"17","author":"Liefeldt","year":"2002","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"2026012114210135300_ehf213341-bib-0026","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMra0800028","article-title":"Myocarditis","volume":"360","author":"Cooper","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012114210135300_ehf213341-bib-0027","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cardfail.2018.11.017","article-title":"Parvovirus B19 in dilated cardiomyopathy: there is more than meets the eye","volume":"25","author":"Verdonschot","year":"2019","journal-title":"J Card Fail"},{"key":"2026012114210135300_ehf213341-bib-0028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3851\/IMP1516","article-title":"Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load","volume":"15","author":"Dennert","year":"2010","journal-title":"Antivir Ther"},{"key":"2026012114210135300_ehf213341-bib-0029","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","article-title":"The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders","volume":"127","author":"Ballow","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2026012114210135300_ehf213341-bib-0030","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/ejhf.1560","article-title":"Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence","volume":"21","author":"Tschope","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114210135300_ehf213341-bib-0031","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cardfail.2018.07.466","article-title":"Parvovirus B19 in endomyocardial biopsy of patients with idiopathic dilated cardiomyopathy: foe or bystander?","volume":"25","author":"Hjalmarsson","year":"2019","journal-title":"J Card Fail"},{"key":"2026012114210135300_ehf213341-bib-0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002361","article-title":"NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy","volume":"3","author":"Streitz","year":"2008","journal-title":"PLoS One"},{"key":"2026012114210135300_ehf213341-bib-0033","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jviromet.2013.06.003","article-title":"Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19","volume":"193","author":"Wolfisberg","year":"2013","journal-title":"J Virol Methods"},{"key":"2026012114210135300_ehf213341-bib-0034","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00395-013-0372-y","article-title":"A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression","volume":"108","author":"Kuhl","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"2026012114210135300_ehf213341-bib-0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78597-4","article-title":"Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure","volume":"10","author":"Pietsch","year":"2020","journal-title":"Sci Rep"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13341","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13341","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/4\/2723\/65568589\/eschf_8_4_2723.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/4\/2723\/65568589\/eschf_8_4_2723.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:25:43Z","timestamp":1769023543000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/4\/2723\/8344346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,5,1]]},"published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13341","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8]]},"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"2020-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}